Sodium Cromoglicate [4%]
Indications
Ophthalmic use: Prevention of acute allergic conjunctivitis, seasonal conjunctivitis, vernal kerato conjunctivitis
Nasal use: It is also used for the symptomatic prevention & treatment of seasonal or perennial allergic rhinitis. Prophylactic treatment for seasonal allergic rhinitis should begin 2 to 3 weeks before exposure to the allergen and should continue throughout the season.
Nasal use: It is also used for the symptomatic prevention & treatment of seasonal or perennial allergic rhinitis. Prophylactic treatment for seasonal allergic rhinitis should begin 2 to 3 weeks before exposure to the allergen and should continue throughout the season.
Description
Sodium Cromoglicate is a type of medicine used to prevent the symptoms of allergies. Sodium Cromoglicate works by acting on mast cells to prevent them from releasing substances that cause the allergic reaction.
Pharmacology
Sodium Cromoglicate inhibits the degranulation of sensitized mast cells which occurs after exposure to specific antigens. Sodium Cromoglicate acts by inhibiting the release of histamine and various membrane derived mediators of inflammation from mast cells. Sodium Cromoglicate has no vasoconstrictor or antihistaminic activity.
Dosage & Administration
For eyes: For Child and Adult: 1 to 2 drops into each eye 2 to 3 times daily.
For nose: For Child and Adult: 1 drop to each nostril 2 to 3 times daily.
For nose: For Child and Adult: 1 drop to each nostril 2 to 3 times daily.
* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Interaction
No evidence of interaction with other drugs has been observed.
Contraindications
This drop is contraindicated in patient with hypersensitivity to Sodium Cromoglicate .
Side Effects
Transient stinging and burning may occur after instillation of this drops. Other symptoms of local irritation have been reported rarely.
Pregnancy & Lactation
Sodium Cromoglicate should be used with caution during pregnancy and only if the expected benefit to the mother is greater than any possible risk to the fetus. There are no known harmful effects when this medicine is used by breastfeeding mothers.
Precautions & Warnings
As this drop contains benzalkonium chloride, patients should not wear contact lenses during treatment with this drop.
Overdose Effects
Overdose is unlikely. In the event of accidental ingestion, symptomatic treatment is recommended.
Therapeutic Class
Mast Cell Stabiliser, Ophthalmic Non-Steroid drugs
Storage Conditions
Store at room temperature and protect from light. Any remaining contents should be discarded 4 weeks after opening. Do not touch dropper tip to any surface since this may contaminate the solution.